Revance Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 28, 2025	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Jan '21 Jan 2, 2021	2016 - 2020
Cash & Equivalents	751.2	176	105.4	331.3	1,752	1,327	Upgrade
Short-Term Investments	-	-	-	176.3	606.2	643	Upgrade
Cash & Short-Term Investments	751.2	176	105.4	507.6	2,358	1,970	Upgrade
Cash Growth	563.60%	66.98%	-79.24%	-78.47%	19.68%	383.84%	Upgrade
Accounts Receivable	716.1	853.7	863.2	884.6	715.7	714.4	Upgrade
Other Receivables	17.4	228.1	338.8	264.6	171.2	212.2	Upgrade
Receivables	733.5	1,082	1,202	1,149	886.9	926.6	Upgrade
Inventory	2,559	2,558	2,694	3,216	2,481	2,313	Upgrade
Prepaid Expenses	237.8	212	246.6	195.7	216.1	193.8	Upgrade
Other Current Assets	22	260	168.6	257.2	157.6	160.5	Upgrade
Total Current Assets	11,420	11,348	11,293	11,530	11,647	10,547	Upgrade
Property, Plant & Equipment	7,386	7,429	7,153	6,926	6,335	5,995	Upgrade
Long-Term Investments	10.7	12.8	8.3	62.6	175.1	146.2	Upgrade
Goodwill	-	838.7	844.8	863.2	876.8	889.5	Upgrade
Other Intangible Assets	1,376	1,338	1,410	1,478	1,495	1,483	Upgrade
Long-Term Accounts Receivable	-	85.8	87.6	88.7	94	103.9	Upgrade
Long-Term Deferred Tax Assets	65.6	65.9	79.5	143.4	218.7	298.7	Upgrade
Other Long-Term Assets	1,152	1,060	1,000	1,008	948.5	902.8	Upgrade
Total Assets	21,472	22,241	21,978	22,102	21,802	20,377	Upgrade
Accounts Payable	2,873	2,411	2,160	2,656	2,369	1,962	Upgrade
Accrued Expenses	-	-	-	5.6	6.2	8.1	Upgrade
Short-Term Debt	-	2	525.6	126.6	58	51.1	Upgrade
Current Portion of Long-Term Debt	688.2	680.4	560.5	1,040	719.8	150.5	Upgrade
Current Portion of Leases	391.6	418.5	378.5	381.2	359	329.9	Upgrade
Current Income Taxes Payable	30.2	88.5	13.4	47.1	157.6	120.4	Upgrade
Current Unearned Revenue	-	351.6	342.4	316.4	291.2	246.8	Upgrade
Other Current Liabilities	882.5	917.8	926.7	893	870.4	994.3	Upgrade
Total Current Liabilities	6,244	6,335	6,389	7,147	6,790	5,206	Upgrade
Long-Term Debt	1,693	1,901	2,419	1,148	1,379	1,938	Upgrade
Long-Term Leases	2,035	2,072	1,986	2,026	1,917	1,897	Upgrade
Long-Term Deferred Tax Liabilities	120.8	245.5	182.1	132.1	125.9	122	Upgrade
Other Long-Term Liabilities	256.4	96.8	89.7	654	715.9	725.9	Upgrade
Total Liabilities	14,696	15,152	15,534	15,063	15,291	14,542	Upgrade
Common Stock	621.1	625.9	598.7	587.8	593.6	597	Upgrade
Additional Paid-In Capital	-	-	-	2.9	2.9	2.9	Upgrade
Retained Earnings	5,209	5,614	5,128	5,070	4,697	4,137	Upgrade
Comprehensive Income & Other	-0.5	-85.3	-181.8	-42.4	-169.2	-237.7	Upgrade
Total Common Equity	5,830	6,155	5,545	5,619	5,124	4,499	Upgrade
Minority Interest	946.5	933.3	899.7	1,421	1,387	1,336	Upgrade
Shareholders' Equity	6,776	7,088	6,445	7,039	6,511	5,835	Upgrade
Total Liabilities & Equity	21,472	22,241	21,978	22,102	21,802	20,377	Upgrade
Total Debt	10,533	10,899	11,659	10,212	10,556	10,168	Upgrade
Net Cash (Debt)	-9,782	-10,723	-11,554	-9,705	-8,198	-8,198	Upgrade
Net Cash Per Share	-176.15	-192.29	-204.64	-163.55	-133.64	-134.19	Upgrade
Filing Date Shares Outstanding	54.07	55.62	55.62	57.7	60.15	60.81	Upgrade
Total Common Shares Outstanding	54.07	55.62	55.62	57.7	60.15	60.81	Upgrade
Working Capital	5,176	5,013	4,904	4,383	4,857	5,341	Upgrade
Book Value Per Share	107.81	110.66	99.69	97.37	85.19	73.99	Upgrade
Tangible Book Value	4,453	3,979	3,290	3,277	2,752	2,126	Upgrade
Tangible Book Value Per Share	82.36	71.53	59.16	56.79	45.75	34.97	Upgrade
Land	-	1,147	1,135	1,101	1,072	1,073	Upgrade
Buildings	-	4,134	4,119	3,916	3,684	3,644	Upgrade
Machinery	-	2,422	2,243	1,904	1,808	1,708	Upgrade
Construction In Progress	-	371.1	422.5	647	424.6	149.7	Upgrade
Leasehold Improvements	-	1,697	1,525	1,430	1,343	1,291	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.